124 related articles for article (PubMed ID: 16378789)
1. Lipid levels and bone mineral density.
Solomon DH; Avorn J; Canning CF; Wang PS
Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378789
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in subjects using central nervous system-active medications.
Kinjo M; Setoguchi S; Schneeweiss S; Solomon DH
Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378792
[TBL] [Abstract][Full Text] [Related]
3. Association between serum cholesterol and bone mineral density.
Makovey J; Chen JS; Hayward C; Williams FM; Sambrook PN
Bone; 2009 Feb; 44(2):208-13. PubMed ID: 18983946
[TBL] [Abstract][Full Text] [Related]
4. HDL cholesterol and bone mineral density in normal-weight postmenopausal women: is there any possible association?
D'Amelio P; Di Bella S; Tamone C; Ravazzoli MG; Cristofaro MA; Di Stefano M; Isaia G
Panminerva Med; 2008 Jun; 50(2):89-96. PubMed ID: 18607332
[TBL] [Abstract][Full Text] [Related]
5. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
6. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
[TBL] [Abstract][Full Text] [Related]
7. Statin lipid-lowering drugs and bone mineral density.
Solomon DH; Finkelstein JS; Wang PS; Avorn J
Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):219-26. PubMed ID: 15386702
[TBL] [Abstract][Full Text] [Related]
8. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
Orso Giacone G
Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
[TBL] [Abstract][Full Text] [Related]
9. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
[TBL] [Abstract][Full Text] [Related]
10. The effect of body composition on blood lipids, leptin, bone mineral density, and nutrition in females.
Sanlier N
Saudi Med J; 2008 Nov; 29(11):1636-42. PubMed ID: 18998016
[TBL] [Abstract][Full Text] [Related]
11. Are thyroid peroxidase antibodies associated with cardiovascular disease risk in patients with subclinical hypothyroidism?
Wells BJ; Hueston WJ
Clin Endocrinol (Oxf); 2005 May; 62(5):580-4. PubMed ID: 15853828
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
[TBL] [Abstract][Full Text] [Related]
15. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
16. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
17. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
18. Association of serum lipid profiles with depressive and anxiety disorders in menopausal women.
Chen CC; Huang TL
Chang Gung Med J; 2006; 29(3):325-30. PubMed ID: 16924895
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
Ghandehari H; Kamal-Bahl S; Wong ND
Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
